Effects of 1 year treatment with pioglitazione vs sulfonylurea on lipid metabolism in type 2 diabetes patients

被引：0
|
作者：
Russo, M. [1 ,2 ]
Carli, F. [1 ]
Vitale, M. [3 ]
Masulli, M. [3 ]
Bozzetto, L. [3 ]
Della Pepa, G. [3 ]
Pezzica, S. [1 ]
Vaccaro, O. [3 ]
Rivellese, A. [3 ]
Gastaldelli, A. [1 ]
机构：
[1] CNR, Inst Clin Physiol, Pisa, Italy
[2] Univ Siena, Siena, Italy
[3] Univ Naples Federico II, Naples, Italy
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
619
引用
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [1] The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment
    Pan, Sheng-Wei
    Yen, Yung-Feng
    Kou, Yu Ru
    Chuang, Pei-Hung
    Su, Vincent Yi-Fong
    Feng, Jia-Yih
    Chan, Yu-Jiun
    Su, Wei-Juin
    CHEST, 2018, 153 (06) : 1347 - 1357
  • [2] Effects of pioglitazone treatment on postprandial lipid metabolism in type 2 diabetes
    Al Majali, K
    Cooper, M
    Adiseshiah, M
    Hurel, S
    Harry, P
    Urquhart, R
    Betteridge, DJ
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 130 - 131
  • [3] CONCOMITANT INSULIN AND SULFONYLUREA THERAPY IN PATIENTS WITH TYPE-II DIABETES - EFFECTS ON GLUCOREGULATION AND LIPID-METABOLISM
    OSEI, K
    ODORISIO, TM
    FALKO, JM
    AMERICAN JOURNAL OF MEDICINE, 1984, 77 (06): : 1002 - 1009
  • [4] Sulfonylurea treatment in type 2 diabetes
    Bester, Kirstin
    Ton, Joey
    Korownyk, Christina
    CANADIAN FAMILY PHYSICIAN, 2018, 64 (04) : 295 - 295
  • [5] Comparison of the effects of glimepiride and glibenclamide on lipid metabolism in patients with type 2 diabetes
    Matsui, J.
    Ogawa, Y.
    Tamasawa, N.
    Matsuki, K.
    Tanabe, J.
    Murakami, H.
    Suda, T.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 506 - 506
  • [6] Effects of pemafibrate on lipid metabolism in patients with hypertriglyceridemia complicated with type 2 diabetes
    Kito, K.
    Nomoto, H.
    Sakuma, I.
    Nakamura, A.
    Cho, K. Y.
    Taneda, S.
    Takeuchi, J.
    Nagai, S.
    Kurihara, Y.
    Aoki, S.
    Atsumi, T.
    Miyoshi, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [7] The effect of combination therapy with pioglitazone and sulfonylurea on the lipid profile in patients with type 2 diabetes
    Mathisen, A
    Egan, J
    Schneider, R
    DIABETES, 1999, 48 : A106 - A106
  • [8] Sulfonylurea vs pioglitazone: effects on endothelial function in type 2 diabetic patients
    Naka, K.
    Papathanassiou, K.
    Kazakos, N.
    Bechlioulis, A.
    Pappas, K.
    Makriyiannis, D.
    Liveris, K.
    Tsatsoulis, A.
    Michalis, L. K.
    EUROPEAN HEART JOURNAL, 2007, 28 : 466 - 466
  • [9] Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients
    Tseng, CH
    Huang, TS
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 70 (02) : 193 - 194
  • [10] Effect of pioglitazone on glucose metabolism in sulfonylurea-treated patients with type 2 diabetes
    Miyazaki, Y
    Mahankali, A
    Matsuda, M
    Cusi, K
    Mandarino, L
    Defronzo, RA
    DIABETES, 2000, 49 : A117 - A118
12345